Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

U.S. may require nearly $7 billion to combat monkeypox outbreak - WaPo

Published 07/26/2022, 06:03 PM
Updated 07/26/2022, 06:05 PM
© Reuters. FILE PHOTO: Test tubes labelled "Monkeypox virus positive" are seen in this illustration taken May 23, 2022. REUTERS/Dado Ruvic/Illustration/File Photo

© Reuters. FILE PHOTO: Test tubes labelled "Monkeypox virus positive" are seen in this illustration taken May 23, 2022. REUTERS/Dado Ruvic/Illustration/File Photo

(Reuters) - The Biden administration estimates it may need nearly $7 billion to deal with the monkeypox outbreak in the United States, the Washington Post reported on Tuesday.

The funding estimate was part of a memo marked to President Joe Biden outlining a series of options, as opposed to a formal funding request, the report said. (https://wapo.st/3oxXimZ)

The White House and the U.S. Department of Health and Human Services did not immediately respond to requests for comment.

© Reuters. FILE PHOTO: Test tubes labelled

The news comes days after the World Health Organization (WHO) declared the monkeypox outbreak a global health emergency.

Nearly 70 countries in which the viral disease is not endemic have reported outbreaks, crossing 17,800 confirmed cases. The United States had reported 3,487 cases by Tuesday.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.